Coty Sets Out Comprehensive Strategy to Double Skincare Sales by FY25
Coty Inc. hosted an Investor Event at its Monaco Skincare R&D center, detailing plans to reach $500M-$600M in skincare sales by FY25. The company raised its revenue and gross margin guidance for 1Q23, fueled by stronger demand and strategic portfolio updates across Prestige brands. Coty expects to achieve 6-8% LFL sales growth and a $955-$965M adjusted EBITDA for FY23. CEO Sue Y. Nabi emphasized the potential of their skincare segment amidst a projected growth of the global skincare market valued at $150 billion.
- Plans to achieve skincare sales of $500M-$600M by FY25.
- Raised 1Q23 revenue and gross margin guidance.
- Expecting 6-8% LFL sales growth for FY23.
- Adjusted EBITDA guidance raised to $955-$965M.
- Continued inflationary pressures affecting financial outlook.
-
Company to Host Investor Event at its Monaco Skincare R&D and
Manufacturing Center of Excellence Today -
Details Plan to Achieve Skincare Sales of
by FY25 and Accelerate Growth in FY26 and Beyond$500m -600M - Unveils New Launches and Expansion Plans for Key Skincare Brands
- Raises 1Q23 Revenue and Gross Margin Guidance
- Reiterates FY23 & Medium-Term Growth Outlook
At the event, Coty will provide a comprehensive update on the Company’s Skincare strategy, one of Coty’s six strategic growth pillars, with a focus on its Prestige brands. The company will detail its distinct and superior skincare intellectual property, upcoming operational and portfolio milestones, early evidence of success, and Coty’s financial goals through FY25 and beyond.
Event Overview
During today’s event, Coty’s Chief Executive Officer,
Skincare Portfolio Update
Coty’s scientific update will focus on the Company’s distinct and superior technologies in five key areas: full-light protection, oxygen delivery, retinol vectorization, DNA repair, and bio-fermented blends. Coty’s research in these critical skincare areas goes back several decades, with key patents extending for the next 5-10 years.
Dr.
Coty’s brand overview and commercial update will center on the Company’s robust portfolio of prestige skincare brands, including
Financial Outlook
With all the key elements of Coty’s strategy now in place, the Company expects to double its skincare revenues from FY22 to FY25, with further acceleration in FY26 and beyond. This coupled with the continued momentum in the rest of the Coty business, reinforces the Company’s commitment to its medium-term financial targets laid out at the Investor Day in
In the near term, Coty is seeing stronger beauty demand, leading the Company to raise it 1QFY23 LFL sales growth outlook to +8
This Q1 upside reinforces Coty’s confidence in its previously issued FY23 guidance, even as the current macro-economic uncertainty factor into the Company’s decision to maintain its FY23, including 6
Webcast Information
The livestream can be accessed on Coty’s Investor Relations website at https://investors.coty.com. The replay of the event and associated presentation materials will also be available under the ‘Events & Presentations’ section following the completion of the event.
About
Founded in
Cautionary Note Regarding Forward-looking Statements
The statements contained in this press release include certain “forward-looking statements” within the meaning of the securities laws. These forward-looking statements reflect Coty’s current views with respect to, among other things, its outlook, expected guidance, trends and strategic information. These forward-looking statements are generally identified by words or phrases, such as “anticipate,” “are going to,” “estimate,” “plan,” “project,” “expect,” “believe,” “intend,” “foresee,” “forecast,” “will,” “may,” “should,” “outlook,” “continue,” “target,” “aim,” “potential” and similar words or phrases. These statements are based on certain assumptions and estimates that Coty considers reasonable and are not guarantees of Coty’s future performance, but are subject to a number of risks and uncertainties, many of which are beyond Coty’s control, which could cause actual events or results to differ materially from such statements, including the factors identified in “Risk Factors” included in Coty’s Annual Report on Form 10-K for the fiscal year ended
Coty provides guidance only on a non-GAAP basis and does not provide reconciliations of such forward-looking non-GAAP measures to GAAP due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation, including adjustments that could be made for restructuring, integration and acquisition-related expenses, amortization expenses, adjustments to inventory, and other charges reflected in our reconciliation of historic numbers, the amount of which, based on historical experience, could be significant.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220921005478/en/
Investor Relations
212-389-7733
Olga_Levinzon@cotyinc.com
Media
+31 621 394495
Antonia_Werther@cotyinc.com
Source:
FAQ
What is Coty's forecast for skincare sales by FY25?
What are Coty's updated revenue expectations for 1Q23?
What financial targets did Coty outline for FY23?
What market opportunities is Coty targeting with its skincare brands?